The use of pregabalin in the treatment of hot flashes

Abstract

Get full access to this article

View all access options for this article.

References

Tamofen [product monograph]. Laval (QC): Sanofi-Aventis Canada, Inc; 2006.

Eligard [product monograph]. Laval (QC): Sanofi-Aventis Canada, Inc; 2010.

Bélisle

Blake

Basson

. Canadian Consensus Conference on menopause, 2006 update. J Obstet Gynaecol Can 2006;28:S7-S94.

Effexor [product monograph]. Kirkland (QC): Pfizer Canada; 2011.

Paroxetine [product monograph]. Dieppe (NB): Sanis Health, Inc; 2011.

Fluoxetine [product monograph]. Dieppe (NB): Sanis Health, Inc; 2011.

Gabapentin [product monograph]. Saint-Laurent (QC): Sivem Pharmaceuticals ULC; 2012.

Pregabalin [product monograph]. Kirkland (QC): Pfizer Canada, Inc; 2010.

Guttuso

Jr.

Gabapentin’s effects on hot flashes and hypothermia. Neurology 2000;54:2161-3.

10.

Presant

Kelly

. Palliation of vasomotor instability (“hot flashes”) using pregabalin. Community Oncol 2007;4:83-4.

11.

Loprinzi

Qin Rui Baclueva

. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol 2010;28:641-7.

12.

Guttuso

Jr. Kurlan

McDermott

. Gabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-45.

13.

Hayes

Carroll

Kelley

. Use of gabapentin for the management of natural or surgical menopausal hot flashes. Ann Pharmacother 2011;45:388-94.

14.

Curran

Andrykowski

Studts

. Short Form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess 1995;7:80-3.

15.

Lorr

McNair

Droppleman

. POMS: Profile of Mood States. Available: www.mhs.com/product.aspx?gr=cli&prod=poms&id=overview (accessed Sept. 23, 2010).

16.

Carpenter

. The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 2001;22:979-89.

17.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.

18.

Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13.